| American Eyecare | |
|
100 W Park Ave, Anaconda, MT 59711-2259 | |
| (406) 563-6471 | |
| (406) 563-7252 |
| Full Name | American Eyecare |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 100 W Park Ave, Anaconda, Montana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053342006 | NPI | - | NPPES |
| 000482137 | Medicaid | MT | |
| 000482256 | Medicaid | MT | |
| D08606062 | Other | MT | SUBMITTER ID |
| P00005738 | Other | MT | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 426 (Montana) | Primary |
| 152W00000X | Optometrist | 490 (Montana) | Secondary |
| 207W00000X | Ophthalmology | 3128 (Montana) | Secondary |
| Provider Name | Bonnie M Gunter |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1417996158 PECOS PAC ID: 1355242637 Enrollment ID: I20040119000779 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis.
The vomeronasal organ (VNO) is an odor detection system that mediates many pheromone-sensitive behaviors. Vomeronasal sensory neurons (VSNs), located in the VNO, are the initial site of interaction with odors and pheromones.
"Clearly, the public has a right to know how well its hospitals are performing but patients should not use the star ratings to judge the quality of care they can expect to receive.
"The World Health Organization said Thursday that governments in the Mekong region must act 'urgently' to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar," Agence France-Presse reports.
› Verified 7 days ago
| Provider Name | David G Vainio |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1780678938 PECOS PAC ID: 4183524176 Enrollment ID: I20100324001140 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis.
The vomeronasal organ (VNO) is an odor detection system that mediates many pheromone-sensitive behaviors. Vomeronasal sensory neurons (VSNs), located in the VNO, are the initial site of interaction with odors and pheromones.
"Clearly, the public has a right to know how well its hospitals are performing but patients should not use the star ratings to judge the quality of care they can expect to receive.
"The World Health Organization said Thursday that governments in the Mekong region must act 'urgently' to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar," Agence France-Presse reports.
› Verified 7 days ago
| Provider Name | Jessica Nicole Lemons |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1497061659 PECOS PAC ID: 5698963700 Enrollment ID: I20150508002138 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis.
The vomeronasal organ (VNO) is an odor detection system that mediates many pheromone-sensitive behaviors. Vomeronasal sensory neurons (VSNs), located in the VNO, are the initial site of interaction with odors and pheromones.
"Clearly, the public has a right to know how well its hospitals are performing but patients should not use the star ratings to judge the quality of care they can expect to receive.
"The World Health Organization said Thursday that governments in the Mekong region must act 'urgently' to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar," Agence France-Presse reports.
› Verified 7 days ago
| Provider Name | Lindsay Michael Vainio |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1962852921 PECOS PAC ID: 2961797725 Enrollment ID: I20161118001715 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis.
The vomeronasal organ (VNO) is an odor detection system that mediates many pheromone-sensitive behaviors. Vomeronasal sensory neurons (VSNs), located in the VNO, are the initial site of interaction with odors and pheromones.
"Clearly, the public has a right to know how well its hospitals are performing but patients should not use the star ratings to judge the quality of care they can expect to receive.
"The World Health Organization said Thursday that governments in the Mekong region must act 'urgently' to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar," Agence France-Presse reports.
› Verified 7 days ago
| Provider Name | Joseph S Lemay |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1356911473 PECOS PAC ID: 5698157998 Enrollment ID: I20220803002033 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis.
The vomeronasal organ (VNO) is an odor detection system that mediates many pheromone-sensitive behaviors. Vomeronasal sensory neurons (VSNs), located in the VNO, are the initial site of interaction with odors and pheromones.
"Clearly, the public has a right to know how well its hospitals are performing but patients should not use the star ratings to judge the quality of care they can expect to receive.
"The World Health Organization said Thursday that governments in the Mekong region must act 'urgently' to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar," Agence France-Presse reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| American Eyecare 100 W Park Ave, Anaconda, MT 59711-2259 Ph: (406) 563-6471 | American Eyecare 100 W Park Ave, Anaconda, MT 59711-2259 Ph: (406) 563-6471 |
News Archive
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis.
The vomeronasal organ (VNO) is an odor detection system that mediates many pheromone-sensitive behaviors. Vomeronasal sensory neurons (VSNs), located in the VNO, are the initial site of interaction with odors and pheromones.
"Clearly, the public has a right to know how well its hospitals are performing but patients should not use the star ratings to judge the quality of care they can expect to receive.
"The World Health Organization said Thursday that governments in the Mekong region must act 'urgently' to stop the spread of drug-resistant malaria which has emerged in parts of Vietnam and Myanmar," Agence France-Presse reports.
› Verified 7 days ago
Anaconda Eye Care Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 112 W 3rd St, Anaconda, MT 59711 Phone: 406-563-5141 | |
Thomas E Yochem, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 112 W 3rd St, Anaconda, MT 59711 Phone: 406-563-5141 | |
Dr. David G Vainio, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 100 W Park Ave, Anaconda, MT 59711 Phone: 406-563-6471 Fax: 406-563-7252 | |
Lindsay Michael Vainio, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 100 W Park Ave, Anaconda, MT 59711 Phone: 406-563-6471 Fax: 406-563-7252 |